Page last updated: 2024-08-24

imiquimod and Lichen Sclerosis

imiquimod has been researched along with Lichen Sclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Mahony, C; Stanley, M; Yesudian, PD1
Bovenschen, HJ; van Kessel, MA; van Lingen, RG1
Badger, J; Dadras, SS; Kong, CS; Taube, JM1
Hengge, UR; Meykadeh, N1

Reviews

1 review(s) available for imiquimod and Lichen Sclerosis

ArticleYear
Differentiated (simplex) vulvar intraepithelial neoplasia: a case report and review of the literature.
    The American Journal of dermatopathology, 2011, Volume: 33, Issue:3

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Vulvar Neoplasms

2011

Other Studies

3 other study(ies) available for imiquimod and Lichen Sclerosis

ArticleYear
Imiquimod use in the genital area and development of lichen sclerosus and lichen planus.
    International journal of STD & AIDS, 2010, Volume: 21, Issue:3

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Circumcision, Male; Condylomata Acuminata; Humans; Imiquimod; Lichen Planus; Lichen Sclerosus et Atrophicus; Male

2010
Vulvitis plasmacellularis circumscripta in pre-existing lichen sclerosus: treatment with imiquimod 5% cream.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:1

    Topics: Adjuvants, Immunologic; Aminoquinolines; Female; Humans; Imiquimod; Lichen Sclerosus et Atrophicus; Middle Aged; Ointments; Plasma Cells; Vulvitis

2010
[Topical immunomodulators in dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts

2003